Clinical Trial Update: Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing imatinib to dasatinib in newly diagnosed chronic phase chronic myeloid leukemia has completed. The update provides completion status f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Sprycel (dasatinib)

Snippet

Sponsor: Newcastle University | Conditions: Myeloid Leukemia, Chronic, Chronic Phase | Phase 3 | Status: COMPLETED